Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > pre-BTD and BTD

<< Previous

Bullboard Posts

Next >>

Comment by FGPstockon Nov 06, 2023 1:50pm

173 Views

Post# 35719809

RE:RE:pre-BTD and BTD

I am not sure how this is good news... what it signals to me is they are having trouble raising money, again, which is not surprising as not too many big investors want to pay .22 for a stock trading at .18-.19. Also, last year they announced they were applying BTD befoire year end, now, a year later, they are supposedly applyhing for pre-BTD, which I thought they are currently now. Regardless, I am sure they will a get their holiday bonuses..

<< Previous

Bullboard Posts

Next >>

Propel steps onto world stage with QuidMarket acquisition